Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
51,513,636
-
Total 13F shares
-
926,617
-
Share change
-
+428,990
-
Total reported value
-
$4,262,000
-
Put/Call ratio
-
123%
-
Price per share
-
$4.60
-
Number of holders
-
28
-
Value change
-
+$2,921,667
-
Number of buys
-
24
-
Number of sells
-
3
Institutional Holders of CAPRICOR THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (CAPR) as of Q2 2020
As of 30 Jun 2020,
CAPRICOR THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (CAPR) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
926,617 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, NORTHERN TRUST CORP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Virtu Financial LLC, VANGUARD GROUP INC, TWO SIGMA INVESTMENTS, LP, GOLDMAN SACHS GROUP INC, MORGAN STANLEY, BlackRock Inc., and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
29
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.